| Literature DB >> 29315230 |
You-Lin Tain1,2, Wei-Chia Lee3, Kay L H Wu4, Steve Leu5, Julie Y H Chan6.
Abstract
Widespread consumption of high-fructose and high-fat diets relates to the global epidemic of hypertension. Hypertension may originate from early life by a combination of prenatal and postnatal nutritional insults. We examined whether maternal high-fructose diet increases vulnerability to post-weaning high-fructose or high-fat diets induced hypertension in adult offspring and determined the underlying mechanisms. Pregnant Sprague-Dawley rats received regular chow (ND) or chow supplemented with 60% fructose (HFR) during the entire pregnancy and lactation periods. Male offspring were onto either the regular chow, 60% fructose, or high-fat diet (HFA) from weaning to 12 weeks of age and assigned to four groups: ND/ND, HFR/ND, HFR/HFR, and HFR/HFA. Maternal high-fructose diet exacerbates post-weaning high-fat diet-induced programmed hypertension. Post-weaning high-fructose and high-fat diets similarly reduced Sirt4, Prkaa2, Prkag2, Ppara, Pparb, and Ppargc1a mRNA expression in offspring kidneys exposed to maternal high-fructose intake. Additionally, post-weaning high-fat diet significantly reduced renal mRNA levels of Ulk1, Atg5, and Nrf2 and induced greater oxidative stress than did high-fructose diet. Although maternal high-fructose intake increases soluble epoxide hydrolase (SEH) expression in the kidney, which was restored by post-weaning high-fructose and high-fat diets. Maternal high-fructose diet programs differential vulnerability to developing hypertension in male offspring in response to post-weaning high-fructose and high-fat diets. Our data implicated that specific therapy targeting on nutrient sensing signals, oxidative stress, and SEH may be a promising approach to prevent hypertension in children and mothers exposed to high-fructose and high-fat consumption.Entities:
Keywords: developmental origins of health and disease (DOHaD); fructose; high-fat; hypertension; nutrient sensing signal; oxidative stress; soluble epoxide hydrolase
Mesh:
Substances:
Year: 2018 PMID: 29315230 PMCID: PMC5793284 DOI: 10.3390/nu10010056
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Quantitative real-time polymerase chain reaction primers sequences.
| Gene | Forward | Reverse |
|---|---|---|
| 5 tggagcaggttgcaggaatcca 3 | 5 tggcttcatgatggcaagtggc 3 | |
| 5 ccctttggaccatgaaaaga 3 | 5 cggatgaaatcaatgtgctg 3 | |
| 5 agctcgcagtggcttatcat 3 | 5 ggggctgtctgctatgagag3 | |
| 5 cagggccttatggtcaagaa 3 | 5 cagcgcatagagatggttca 3 | |
| 5 gtgtgggagaagctctgagg 3 | 5 agaccacacccagaagatgc 3 | |
| 5 agaagttgcaggaggggatt 3 | 5 ttcttgatgacctgcacgag 3 | |
| 5 gatcagcgtgcatgtgttct 3 | 5 cagcagtccgtctttgttga 3 | |
| 5 ctttatggagcctaagtttgagt 3 | 5 gttgtcttggatgtcctcg 3 | |
| 5 cccattgagggctgtgatct 3 | 5 tcagtgaaatgccggagtca 3 | |
| 5 cccattgagggctgtgatct 3 | 5 tcagtgaaatgccggagtca 3 | |
| 5 gagtacccgcaccagaatgt 3 | 5 gctgtgtagggtttccgtgt 3 | |
| 5 ttggcctactgttcgatcttctt 3 | 5 ggacagtgcagaaggtcctttt 3 | |
| 5 cacagcctcggctttgaga 3 | 5 tcacatacccatggctgacatc 3 | |
| 5 gccgcggtaattccagctcca 3 | 5 cccgcccgctcccaagatc 3 |
Antibodies used for Western blotting.
| Antibody | Host | Source | Product Number | Dilution |
|---|---|---|---|---|
| pAMPKα2 | Rabbit | Santa Cruz Biotechnology | SC-33524 | 1:1000 |
| PPARα | Rabbit | Abcam plc. | ab8934 | 1:1000 |
| PPARβ | Mouse | Santa Cruz Biotechnology | SC-74517 | 1:1000 |
| PGC-1α | Rabbit | Santa Cruz Biotechnology | SC-13067 | 1:1000 |
| SEH | Rabbit | Santa Cruz Biotechnology | SC-25797 | 1:1000 |
pAMPKα2: phosphorylated 5′ adenosine monophosphate-activated protein kinase 2α; PPARα: peroxisome proliferator-activated receptor α; PPARβ: peroxisome proliferator-activated receptor β; PGC-1α: PPAR-γ coactivator-1α; SHE: soluble epoxide hydrolase.
Summary of weight, blood pressures, and functional parameters in male offspring exposed to maternal high-fructose intake and post-weaning high-fat diet at 12 weeks of age.
| Groups | ND/ND | HFR/ND | HFR/HFR | HFR/HFA |
|---|---|---|---|---|
| Mortality | 0% | 0% | 0% | 0% |
| Body weight (g) | 407 ± 8 | 398 ± 10 | 355 ± 18 a,b | 407 ± 13 |
| Left kidney weight (g) | 1.96 ± 0.09 | 1.68 ± 0.05 a | 2.00 ± 0.14 | 1.57 ± 0.1 a |
| Left kidney weight/100 g body weight | 0.38 ± 0.01 | 0.42 ± 0.01 | 0.58 ± 0.05 a,b | 0.39 ± 0.02 c |
| Systolic blood pressure (mm Hg) | 140 ± 2 | 154 ± 4 a | 155 ± 2 a | 167 ± 5 a,b,c |
| Diastolic blood pressure (mm Hg) | 82 ± 2 | 80 ± 2 | 90 ± 3 a,b | 96 ± 4 a,b |
| Mean arterial pressure (mm Hg) | 101 ± 1 | 104 ± 1 | 112 ± 2 a,b | 119 ± 4 a,b,c |
| Creatinine (μM) | 19.9 ± 0.6 | 16.2 ± 0.6 | 16.1 ± 1.7 | 18.3 ± 1.3 |
HFR/ND, maternal high-fructose intake; HFR/HFR, maternal high-fructose plus post-weaning high-fructose intake; HFR/HFA, maternal high-fructose plus post-weaning high-fat intake. n = 8/group. a p < 0.05 vs. ND/ND; b p < 0.05 vs. HFR/ND; c p < 0.05 vs. HFR/HFR.
Figure 1Effect of maternal and post-weaning high-fructose (HFR) and post-weaning high-fat (HFA) intake on systolic blood pressure in 12-week-old male offspring. * p < 0.05 vs. ND/ND; # p < 0.05 vs. HFR/ND; † p < 0.05 vs. HFR/HFR.
Figure 2Effect of maternal and post-weaning high-fructose (HFR) and post-weaning high-fat (HFA) intake on mRNA expression of (A) silent information regulator transcript 1 (SIRT1) and 4 (SIRT4); (B) AMP-activated protein kinase (AMPK) α-, β-, and γ-subunits; and (C) peroxisome proliferator-activated receptor (PPAR) α-, β-, and γ-isoforms and PPARγ coactivator-1α (PGC-1α) in male offspring kidneys at 12 weeks of age. n = 8/group. * p < 0.05 vs. ND/ND.
Figure 3(A) Representative Western blots and relative abundance of (B) phosphor-AMPKα2 (63 kDa); (C) PPARα (52 kDa); (D) PPARβ (52 kDa); and (E) PGC-1α (90 kDa) in offspring kidneys at 12 weeks of age. n = 8/group. * p < 0.05 versus ND/ND; # p < 0.05 versus HFR/ND.
Figure 4(A) Light micrographs illustrating immunostaining for 8-hydroxydeoxyguanosine (8-OHdG) in the kidney in male offspring at 12 weeks of age. Bar = 50 μm; (B) quantitative analysis of 8-OHdG-positive cells per microscopic field (400×); Effect of maternal and post-weaning high-fructose (HFR) and post-weaning high-fat (HFA) intake on mRNA expression of (C) Nfr2, (D) Ulk1, and (E) Atg5 in male offspring kidneys at 12 weeks of age. n = 8/group. * p < 0.05 vs. ND/ND; # p < 0.05 vs. HFR/ND; † p < 0.05 vs. HFR/HFR.
Plasma levels of l-arginine, l-citrulline, ADMA, and SDMA in male offspring exposed to maternal high fructose intake and post-weaning high-fat diet at 12 weeks of age.
| Groups | ND/ND | HFR/ND | HFR/HFR | HFR/HFA |
|---|---|---|---|---|
| 288.3 ± 6.7 | 226.4 ± 9.1 | 135.1 ± 2.3 a,b | 150.3 ± 4.0 a,b | |
| 57.2 ± 1.1 | 48.5 ± 1.5 | 43.2 ± 1.2 | 56.6 ± 1.6 | |
| ADMA (µM) | 0.97 ± 0.02 | 1.06 ± 0.04 | 0.81 ± 0.01 | 0.86 ± 0.01 |
| SDMA (µM) | 0.61 ± 0.01 | 0.58 ± 0.01 | 0.5 ± 0.01 | 0.52 ± 0.01 |
| 226 ± 3 | 229 ± 11 | 167 ± 1 a,b | 175 ± 4 a,b |
HFR/ND: maternal high-fructose intake; HFR/HFR: maternal high-fructose plus post-weaning high-fructose intake; HFR/HFA: maternal high-fructose plus post-weaning high-fat intake; ADMA: asymmetric dimethylarginine; SDMA: symmetric dimethylarginine; n = 8/group; a p < 0.05 vs. ND/ND; b p < 0.05 vs. HFR/ND.
Figure 5Effect of maternal and post-weaning high-fructose (HFR) and post-weaning high-fat (HFA) intake on mRNA expression of (A) Ephx2 and (B) soluble epoxide hydrolase (SEH) protein (62 kDa); and (C) light micrographs illustrating immunostaining for SEH in the kidney in male offspring at 12 weeks of age. Bar = 50 μm. n = 8/group; * p < 0.05 vs. ND/ND; # p < 0.05 vs. HFR/ND.